FarmavitaR+

1. Pricing and Reimbursement Strategies
(Reports/Market Report)

Pricing and Reimbursement Strategies for Diagnostics: Overcoming reimbursement issues and navigating the regulatory environment The reimbursement for diagnostics is the key requirement for both the ...

2. Long-term pricing & reimbursement strategies to penetrate significant growth markets
(Events/Events)

... to increase market and patient access for the long-term. Why Attend? Hear experiences from policy makers and industry experts regarding strategies to contain and manage chronic disease growth with ...

3. Drug Repositioning & R&D Enhancement
(Events/Events)

... to benchmark best practices with their industry peers in order to develop sound strategies for drug repositioning.  Key conference topics: Grasp the most recent regulatory requirements for Review ...

4. Counterfeit of medical products
(Regulatory Affairs/EMEA)

... systems of a medical product to its source and risk management and prevention strategies like multisectorial training. Preventive measures also comprise awareness-raising campaigns, supervision of the ...

5. The Top 10 Biosimilar Players
(Reports/Market Report)

... market are identified and the leading companies in this sector are profiled in detail. This report examines the portfolio sales performances, pipelines and growth strategies of each of the top 10 biosimilars ...

6. New Approaches to Pharma R&D
(Reports/Market Report)

New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency With industry consolidation, the economic downturn, and an increasing threat from generics, pharma companies are coming ...

7. Drug repositioning
(Regulatory Affairs/Other issues)

Drug repositioning strategies: a different approach to innovation With increased investment in R&D largely failing to fill drug development pipelines, the pharma industry is looking to get more ...

8. Early Stage Drug Safety Strategies and Risk Management
(Reports/Market Report)

Maximizing opportunities towards achieving clinical success For the last few years the biggest pharma companies have started to bring new technologies for drug safety prediction into the discovery ...

9. Valuing Pharmaceutical Innovation
(Reports/Market Report)

Valuing Pharmaceutical Innovation: Pricing and reimbursement for innovative therapies Pricing and reimbursement strategies for innovative new drugs require significant evidence of beneficial clinical ...

10. The Top 10 Generic Pharmaceutical
(Reports/Company Report)

... market, compare the performances and portfolios of leading companies and benchmark their strategies with this report. Compare the performances and growth strategies of leading generics companies and discover ...

11. Rx-to-OTC Strategies
(Reports/Market Report)

Rx-to-OTC Strategies: Maximizing the Commercial Potential of an Rx-to-OTC Switch   With the growing cost of developing novel drugs, combined with the fact that fewer such drugs are gaining ...

12. Optimizing Brand Lifecycle Management
(Reports/Market Report)

Optimizing Brand Lifecycle Management: Winning Strategies to Maximize Revenue in the Face of Growing Generic Competition As competitive pressures from the entry of generics post-patent expiry and new ...

13. Drug Repositioning Strategies
(Reports/Market Report)

Drug Repositioning Strategies - Serendipity by design Drug repositioning has several advantages over traditional discovery-reduced cost, risk and time to market-compared with traditional discovery, ...

14. Online Patient Recruitment
(Reports/Market Report)

Online Patient Recruitment Strategies - Optimizing the clinical trial process With the rising costs, length and complexity of clinical trials, drug development is subject to huge delays, translating ...

15. Clinical Trial Design
(Clinical Trilas/European Union)

... strategies. Read more...  ...

16. eHealth for the Pharmaceutical Industry
(Reports/Market Report)

... industry to develop effective multi-channel marketing strategies. It is advisable for stakeholders to invest in targeted initiatives that meet the specific information needs and support the decision making ...

17. Benchmarking Patent Expiries
(Reports/Company Report)

... in. Manufacturers need to be aware of country specific incentives and barriers to generic prescribing in order to formulate their specific brand defense strategies. Branded pharmaceuticals also experience ...

18. Disease Management and Drug Adherence
(Reports/Company Report)

Disease Management and Drug Adherence:  Strategies to support patients and enhance treatment persistence Failure to take medication as prescribed significantly increases the risk that patients ...

19. R&D Strategies
(Reports/Company Report)

... identify R&D strategies to improve R&D productivity. Over the last decade, significant investment in novel technologies has failed to yield a substantial increase in innovative drugs. To drive up ...

20. Market Trends
(Reports/Market Report)

... never been more important for pharmaceutical companies. Therefore, to ensure a successful launch, manufacturers must employ a multitude of timely strategies to ensure their product enter the market as ...